Gastroenteritis: Clinical Trials

5 trials for Gastroenteritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 enrolling by invitation. 5 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Enrolling by invitation 5
Phase 32Enrolling by invitation 2
Phase 11Enrolling by invitation 1

Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Seaweed Extract (Fucoidan) for Gut Inflammation in Ulcerative Colitis
Low molecular weight fucoidan and standard care, Placebo and standard of care - Ulcerative Colitis (UC)
Phase 1 / Phase 2Enrolling by invitationAllama Iqbal Medical College902026-08-012026-08-26
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
SPY001, SPY002, SPY003 - Ulcerative Colitis, Inflammatory Bowel Diseases
Phase 2Enrolling by invitationSpyre Therapeutics, Inc.6452026-06-082026-10-27
Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum
budesonide, omeprazole (proton pump inhibitor) - Crohn Disease (CD)
Phase 2 / Phase 3Enrolling by invitationMedical University of Warsaw1142024-07-302024-12-06
Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy
Alginos Oral Suspension - Breast Carcinoma
Phase 2Enrolling by invitationTaipei City Hospital902024-02-152025-05-06
Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Fecal microbiota transplantation (FMT) - Ulcerative Colitis, Fecal Microbiota Transplantation
Phase 2 / Phase 3Enrolling by invitationSeoul National University Hospital302023-07-192025-09-12

Narrower conditions

Colitis, Ulcerative (3)  ·  Colitis (2)  ·  Breast Neoplasms (1)  ·  Crohn Disease (1)  ·  Esophagitis (1)  ·  Inflammatory Bowel Diseases (1)  ·  Mucositis (1)  ·  Ulcer (1)

Broader conditions

Digestive System Diseases (5)  ·  Gastrointestinal Diseases (5)  ·  Intestinal Diseases (4)  ·  Colonic Diseases (3)  ·  Inflammatory Bowel Diseases (3)  ·  Breast Diseases (1)  ·  Colitis (1)  ·  Esophageal Diseases (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Skin Diseases (1)

Interventions

Alginates (1)  ·  Budesonide (1)  ·  Fecal Microbiota Transplantation (1)  ·  Omeprazole (1)  ·  Proton Pump Inhibitors (1)  ·  Standard of Care (1)

Sponsors

Allama Iqbal Medical College (1)  ·  Medical University of Warsaw (1)  ·  Seoul National University Hospital (1)  ·  Spyre Therapeutics, Inc. (1)  ·  Taipei City Hospital (1)

Countries

Poland (2)  ·  South Korea (2)  ·  Taiwan (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Chile (1)  ·  Czechia (1)  ·  Georgia (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Italy (1)

Top investigators

Rozina Shahadat Khan, MBBS, M.PHIL,MSPH, CHPE,PHDHND (1)  ·  Yi-Sheng Chou, M.D (1)

NIH funding

2025 (1)